Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone

The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Saal, Christoph, Poma, Marco, Burini, Edoardo, Theuerkorn, Vedad, Becker, Axel
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Saal, Christoph Poma, Marco Burini, Edoardo Theuerkorn, Vedad Becker, Axel
description	The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ755922A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ755922A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ755922A3</originalsourceid><addsrcrecordid>eNqFi7EKwjAURbs4iPoLklGHN7Q2iqOI4tTJSZES6isNJHmPpKhB_Hc1uDsdDvfcYXav6IZGND6GXhmjHYqWvA2CWpHDrISnOC9BWe0I5Ne5Q0ePmBjNHDh6bfVVOyghmhRewGLfRfMSwJrRpzWHVHviz9_hOBu0ygSc_DjKpvvdcXsAZKoxsGrQYV9Xp5WU66LYLP4Gb3t4Qrk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone</title><source>esp@cenet</source><creator>Saal, Christoph ; Poma, Marco ; Burini, Edoardo ; Theuerkorn, Vedad ; Becker, Axel</creator><creatorcontrib>Saal, Christoph ; Poma, Marco ; Burini, Edoardo ; Theuerkorn, Vedad ; Becker, Axel</creatorcontrib><description>The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220701&DB=EPODOC&CC=NZ&NR=755922A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220701&DB=EPODOC&CC=NZ&NR=755922A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Saal, Christoph</creatorcontrib><creatorcontrib>Poma, Marco</creatorcontrib><creatorcontrib>Burini, Edoardo</creatorcontrib><creatorcontrib>Theuerkorn, Vedad</creatorcontrib><creatorcontrib>Becker, Axel</creatorcontrib><title>Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone</title><description>The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFi7EKwjAURbs4iPoLklGHN7Q2iqOI4tTJSZES6isNJHmPpKhB_Hc1uDsdDvfcYXav6IZGND6GXhmjHYqWvA2CWpHDrISnOC9BWe0I5Ne5Q0ePmBjNHDh6bfVVOyghmhRewGLfRfMSwJrRpzWHVHviz9_hOBu0ygSc_DjKpvvdcXsAZKoxsGrQYV9Xp5WU66LYLP4Gb3t4Qrk</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Saal, Christoph</creator><creator>Poma, Marco</creator><creator>Burini, Edoardo</creator><creator>Theuerkorn, Vedad</creator><creator>Becker, Axel</creator><scope>EVB</scope></search><sort><creationdate>20220701</creationdate><title>Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone</title><author>Saal, Christoph ; Poma, Marco ; Burini, Edoardo ; Theuerkorn, Vedad ; Becker, Axel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ755922A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Saal, Christoph</creatorcontrib><creatorcontrib>Poma, Marco</creatorcontrib><creatorcontrib>Burini, Edoardo</creatorcontrib><creatorcontrib>Theuerkorn, Vedad</creatorcontrib><creatorcontrib>Becker, Axel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Saal, Christoph</au><au>Poma, Marco</au><au>Burini, Edoardo</au><au>Theuerkorn, Vedad</au><au>Becker, Axel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone</title><date>2022-07-01</date><risdate>2022</risdate><abstract>The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_NZ755922A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A19%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Saal,%20Christoph&rft.date=2022-07-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ755922A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true